Ownership Summary
The institutional landscape for Mangoceuticals, Inc. (NASDAQ:MGRX) includes 10 filers as of the latest reporting cycle ending September 2025.
- The percentage of Mangoceuticals owned by institutions changed from 8.1% in June 2025 to 6.1% in September 2025, marking a slight down trend.
- On a quarter-over-quarter basis, institutional holdings shifted by 39.07%, with a year-over-year a decrease of 28.57% in the count of filers.
- Of these 10 institutional investors, 6 increased their holdings in Mangoceuticals, while 1 of them reduced positions, and 3 investors maintained their exposure.
- This class of investors increased its holdings in Mangoceuticals to 346.04K shares for the 13F-cycle ending September 2025, up by 97.21K shares quarter on quarter, and down 1.01Mn shares year over year.
- The top institutional stake in Mangoceuticals as of September 30, 2025 belongs to VANGUARD GROUP INC, which owns 192.00K shares, or 3.40% of the company.
- Among the most significant buyers of Mangoceuticals during September 2025 were GEODE CAPITAL MANAGEMENT, LLC (61.48K), NORTHERN TRUST CORP (18.96K), VANGUARD GROUP INC (9.39K), Sunbelt Securities, Inc. (7.00K), ROYAL BANK OF CANADA (451).
- Leading sellers of Mangoceuticals stock in September 2025 included UBS Group AG (76).
- The top 10 institutional holders of Mangoceuticals for the quarter ending September 2025 included VANGUARD GROUP INC (192.00K), GEODE CAPITAL MANAGEMENT, LLC (87.97K), Ackerman Capital Advisors, LLC (34.50K), NORTHERN TRUST CORP (18.96K), Sunbelt Securities, Inc. (7.00K), OSAIC HOLDINGS, INC. (2.88K), Steward Partners Investment Advisory, LLC (2.09K), ROYAL BANK OF CANADA (451), BANK OF AMERICA CORP /DE/ (176), UBS Group AG (3).